Latest filings (excl ownership)
ARS
2023 FY
Annual report to shareholders
15 Apr 24
DEF 14A
Definitive proxy
15 Apr 24
10-K
2023 FY
Annual report
21 Mar 24
8-K
Regulation FD Disclosure
21 Mar 24
8-K
Results of Operations and Financial Condition
21 Mar 24
8-K
Regulation FD Disclosure
8 Jan 24
8-K
Rockwell Medical Amends Loan and Security Agreement with Innovatus Life Sciences Lending Fund
8 Jan 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
8-K
Rockwell Medical Announces Third Quarter 2023 Results
14 Nov 23
8-K
Regulation FD Disclosure
14 Nov 23
8-K
Departure of Directors or Certain Officers
17 Oct 23
8-K
Entry into a Material Definitive Agreement
21 Sep 23
8-K
Departure of Directors or Certain Officers
15 Sep 23
8-K
Regulation FD Disclosure
12 Sep 23
EFFECT
Notice of effectiveness
23 Aug 23
CORRESP
Correspondence with SEC
21 Aug 23
UPLOAD
Letter from SEC
18 Aug 23
S-8
Registration of securities for employees
14 Aug 23
S-3
Shelf registration
14 Aug 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
8-K
Rockwell Medical Announces Second Quarter 2023 Results
14 Aug 23
8-K
Rockwell Medical Acquires Hemodialysis Concentrates Business from Evoqua Water Technologies
11 Jul 23
8-K
Submission of Matters to a Vote of Security Holders
23 May 23
8-K
Regulation FD Disclosure
15 May 23
10-Q
2023 Q1
Quarterly report
15 May 23
8-K
Rockwell Medical Announces First Quarter 2023 Results
15 May 23
ARS
2022 FY
Annual report to shareholders
17 Apr 23
DEF 14A
Definitive proxy
17 Apr 23
8-K/A
Changes in Registrant's Certifying Accountant
14 Apr 23
8-K
Changes in Registrant's Certifying Accountant
13 Apr 23
8-K
Regulation FD Disclosure
10 Apr 23
10-K
2022 FY
Annual report
30 Mar 23
8-K
Rockwell Medical Announces Fourth Quarter and Full-Year 2022
30 Mar 23
8-K
Regulation FD Disclosure
1 Feb 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
8-K
Rockwell Medical Provides Business Strategy Update and Announces Third Quarter 2022 Financial and Operational Results
14 Nov 22
S-8
Registration of securities for employees
15 Aug 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
8-K
Rockwell Medical Announces Second Quarter 2022 Results
15 Aug 22
424B5
Prospectus supplement for primary offering
26 Jul 22
Latest ownership filings
4
Mark Strobeck
19 Mar 24
4
MEGAN C. TIMMINS
19 Mar 24
4
Jesse Neri
15 Mar 24
4
Mark Strobeck
15 Mar 24
4
MEGAN C. TIMMINS
15 Mar 24
SC 13G/A
ARMISTICE CAPITAL, LLC
14 Feb 24
4/A
Joan Lau
6 Feb 24
3/A
Joan Lau
6 Feb 24
4
Jesse Neri
18 Oct 23
4
Joan Lau
18 Oct 23
3
Jesse Neri
18 Oct 23
3
Joan Lau
18 Oct 23
SC 13D/A
Richmond Brothers, Inc.
6 Sep 23
4
Andrea Heslin Smiley
25 May 23
4
Robert S Radie
25 May 23
4
Allen Nissenson
25 May 23
4
MARK H RAVICH
25 May 23
4
JOHN G COOPER
25 May 23
4
MEGAN C. TIMMINS
21 Mar 23
4
Marc L Hoffman
21 Mar 23
4
Mark Strobeck
21 Mar 23
4
Paul E McGarry
21 Mar 23
SC 13G
Richmond Brothers, Inc.
23 Feb 23
SC 13G
ARMISTICE CAPITAL, LLC
14 Feb 23
SC 13G/A
DAVITA INC.
14 Feb 23
4
Marc L Hoffman
13 Sep 22
4
MEGAN C. TIMMINS
13 Sep 22
4
Paul E McGarry
13 Sep 22
4
RUSSELL SKIBSTED
13 Sep 22
4
Mark Strobeck
5 Jul 22
3
Mark Strobeck
5 Jul 22
SC 13D/A
Richmond Brothers, Inc.
23 Jun 22
4
Robert S Radie
9 Jun 22
4
MARK H RAVICH
9 Jun 22
4
JOHN G COOPER
9 Jun 22
4
Andrea Heslin Smiley
9 Jun 22
4
Allen Nissenson
9 Jun 22
SC 13G
DAVITA INC.
18 Apr 22
SC 13G/A
BlackRock Inc.
24 Feb 22
4
MEGAN C. TIMMINS
18 Aug 21